The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity
Open accessAbstract
Telomere length is a marker of biological aging. Short leukocyte telomere length has been associated with various conditions including cardiovascular disorders. Here, we evaluated if patients with hypertrophic cardiomyopathy have altered leukocyte telomere length and whether this is associated with disease severity. A quantitative polymerase chain reaction-based method was used to measure peripheral blood leukocyte telomere length in 59 healthy control subjects and a well-characterized cohort of 88 patients diagnosed with hypertrophic cardiomyopathy: 32 patients with non-obstructive cardiomyopathy (HNCM) and 56 patients with obstructive cardiomyopathy (HOCM). We observed shorter leukocyte telomeres in both HNCM and HOCM patients compared to healthy controls. Furthermore, leukocyte telomere length was inversely associated with HCM even after adjusting for age and sex. Telomere length of HOCM patients was also inversely correlated with left ventricular outflow tract obstruction. Therefore, HOCM patients were categorized by tertiles of telomere length. Patients in the first tertile (shortest telomeres) had a significantly increased left ventricular posterior wall thickness at end-diastole and higher left ventricular outflow tract gradients, whereas the left ventricular end-diastolic diameter was lower compared with patients in the second and third tertile. In summary, telomere length is associated with the severity of the disease in the HOCM subtype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Short telomeres were also observed in a large independent cohort, with the severity of hypertrophic cardiomyopathy correlating with the telomere length of leukocyte telomeres109.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [109]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
Oxidative stress shortens telomeres
von Zglinicki, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02110-2 · Cited by 2,524
Switching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Olovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Hypertrophic Cardiomyopathy: The Therapeutic Role of Calcium Antagonists
(1982) · Springer eBooks · doi:10.1007/978-3-642-68282-7 · Cited by 1,756
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403
Maron, B. J., & Maron, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60397-3 · Cited by 1,231
Cited by
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Evangelou, K., Vasileiou, P. V. S., Papaspyropoulos, A., Hazapis, O. G., Petty, R., Demaria, M., & Gorgoulis, V. G. (2022) · Physiological Reviews · doi:10.1152/physrev.00007.2022 · Cited by 135
Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy
Sonnenschein, K., Wilczek, A. L., de Gonzalo‐Calvo, D., Pfanne, A., Derda, A. A., Zwadlo, C., Bavendiek, U., Bauersachs, J. K., Fiedler, J., & Thum, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-56617-2 · Cited by 81
Self-citationWhat Causes Hypertrophic Cardiomyopathy?
Maron, B. A., Wang, R., Carnethon, M. R., Rowin, E. J., Loscalzo, J., Maron, M. S., & Maron, M. S. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.06.017 · Cited by 63
Song, N., Li, Z., Qin, N., Howell, C. R., Wilson, C. L., Easton, J. B., Mulder, H. L., Edmonson, M. N., Rusch, M., Zhang, J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2503 · Cited by 51
“For example, negative associations between LTL and obesity, hypertension, or cardiomyopathy have been reported in the general population (10, 44, 45).”
Background
Metadata
- Authors
- Chatterjee, S., de Gonzalo-Calvo, D., Derda, A. A., Schimmel, K., Sonnenschein, K., Bavendiek, U., Bauersachs, J., Bär, C., & Thum, T.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Bär, Christian
- Thum, Thomas
- ORCID
- Venue
- Scientific Reports
- Published
- 2018-07-25
- Volume
- 8
- Issue
- 1
- Pages
- 11227-11227
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC6060137
- OpenAlex
- W2883218414
- Cited by
- 21
- References
- 36
- Citations by year
- 2025: 4 · 2024: 6 · 2022: 6 · 2020: 3 · 2019: 2
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Ministerio de Econom&#x00ED;a y Competitividad (IJCI-2016-29393)
- Deutsche Forschungsgemeinschaft (KFO311)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- leukocyte telomere length, hypertrophic cardiomyopathy, hypertrophic obstructive cardiomyopathy, non-obstructive hypertrophic cardiomyopathy, disease severity, left ventricular outflow tract obstruction, left ventricular wall thickness, biological aging, telomere shortening
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cardiomyopathy, Hypertrophic, Female, Humans, Leukocytes, Male, Middle Aged, Severity of Illness Index, Telomere, Telomere Homeostasis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity. https://app.cochat.ai/papers/10.1038/s41598-018-29072-8
- The paper
- Chatterjee, S., de Gonzalo-Calvo, D., Derda, A. A., Schimmel, K., Sonnenschein, K., Bavendiek, U., Bauersachs, J., Bär, C., & Thum, T. (2018). Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity. Scientific Reports. https://doi.org/10.1038/s41598-018-29072-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.